These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30445530)

  • 1. Repeat renal biopsy improves the Oxford classification-based prediction of immunoglobulin A nephropathy outcome.
    Jullien P; Laurent B; Berthoux F; Masson I; Dinic M; Claisse G; Thibaudin D; Mariat C; Alamartine E; Maillard N
    Nephrol Dial Transplant; 2020 Jul; 35(7):1179-1186. PubMed ID: 30445530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.
    Jebali H; Ghabi H; Mami I; Kaab BB; Fatma LB; Smaoui W; Haouet S; Mahjouba HB; Hassan M; Hmida FB; Raies L; Zouaghi MK
    Saudi J Kidney Dis Transpl; 2020; 31(6):1366-1375. PubMed ID: 33565449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To evaluate the utility of Oxford classification in predicting renal outcome in IgA nephropathy patients.
    Saleem N; Nasir H; Anwar F; Aziz M; Khurshid K; Bashir S; Khan A
    Int Urol Nephrol; 2024 Jan; 56(1):345-353. PubMed ID: 37378850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathy.
    Park KS; Han SH; Kie JH; Nam KH; Lee MJ; Lim BJ; Kwon YE; Kim YL; An SY; Kim CH; Doh FM; Koo HM; Oh HJ; Kang SW; Choi KH; Jeong HJ; Yoo TH
    Hum Pathol; 2014 Feb; 45(2):236-43. PubMed ID: 24439222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
    Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical importance of the updated Oxford classification in allograft IgA nephropathy.
    Park S; Go H; Baek CH; Kim YH; Kim YC; Yang SH; Lee JP; Min SI; Ha J; Song EY; Kim YS; Park SK; Lee H; Moon KC
    Am J Transplant; 2019 Oct; 19(10):2855-2864. PubMed ID: 31017369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for a systematic review of the application of the kidney failure risk equation and Oxford classification in estimating prognosis in IgA nephropathy.
    Toal M; Fergie R; Quinn M; Hill C; O'Neill C; Maxwell AP
    Syst Rev; 2024 May; 13(1):122. PubMed ID: 38704598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
    Bellur SS; Roberts ISD; Troyanov S; Royal V; Coppo R; Cook HT; Cattran D; Arce Terroba Y; Asunis AM; Bajema I; Bertoni E; Bruijn JA; Cannata-Ortiz P; Casartelli D; Maria Di Palma A; Ferrario F; Fortunato M; Furci L; Gakiopoulou H; Galesic Ljubanovic D; Giannakakis K; Gomà M; Gröne HJ; Gutiérrez E; Asma Haider S; Honsova E; Ioachim E; Karkoszka H; Kipgen D; Maldyk J; Mazzucco G; Orhan D; Ozluk Y; Pantzaki A; Perkowska-Ptasinska A; Riispere Z; Soderberg MP; Steenbergen E; Stoppacciaro A; Sundelin Von Feilitzen B; Tardanico R
    Nephrol Dial Transplant; 2019 Oct; 34(10):1681-1690. PubMed ID: 30561721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
    Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Capabilities of Three Widely Used Pathology Classification Systems and a Simplified Classification (Beijing Classification) in Primary IgA Nephropathy.
    Duan SW; Mei Y; Liu J; Chen P; Li P; Chen YZ; Lin SP; Zhang XG; Liu JN; Sun XF; Xie YS; Cai GY; Liu SW; Wu J; Chen XM
    Kidney Blood Press Res; 2019; 44(5):928-941. PubMed ID: 31461707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of the Oxford classification of IgA nephropathy to predict renal survival.
    Alamartine E; Sauron C; Laurent B; Sury A; Seffert A; Mariat C
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2384-8. PubMed ID: 21885791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Oxford classification of IgA nephropathy: a single-center study in Korean adults.
    Lee H; Yi SH; Seo MS; Hyun JN; Jeon JS; Noh H; Han DC; Hwang SD; Jin SY; Kwon SH
    Korean J Intern Med; 2012 Sep; 27(3):293-300. PubMed ID: 23019394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S; Söderberg MP; Berg UB
    Nephrol Dial Transplant; 2012 Feb; 27(2):715-22. PubMed ID: 21750154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
    Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
    Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Oxford classification as a predictor of prognosis in patients with IgA nephropathy.
    Kang SH; Choi SR; Park HS; Lee JY; Sun IO; Hwang HS; Chung BH; Park CW; Yang CW; Kim YS; Choi YJ; Choi BS
    Nephrol Dial Transplant; 2012 Jan; 27(1):252-8. PubMed ID: 21606384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implication of crescentic lesions in immunoglobulin A nephropathy.
    Lee MJ; Kim SJ; Oh HJ; Ko KI; Koo HM; Kim CH; Doh FM; Yoo TH; Kang SW; Choi KH; Lim BJ; Jeong HJ; Han SH
    Nephrol Dial Transplant; 2014 Feb; 29(2):356-64. PubMed ID: 24081867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of the Oxford classification of IgA nephropathy to predict renal outcome].
    Peng YH; Su Y; Zhao YJ; Lin CN; Sun GF; Li H; Yu Y; Huang QY; Ye W; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):102-7. PubMed ID: 23469800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease.
    Kawamura T; Joh K; Okonogi H; Koike K; Utsunomiya Y; Miyazaki Y; Matsushima M; Yoshimura M; Horikoshi S; Suzuki Y; Furusu A; Yasuda T; Shirai S; Shibata T; Endoh M; Hattori M; Katafuchi R; Hashiguchi A; Kimura K; Matsuo S; Tomino Y;
    J Nephrol; 2013; 26(2):350-7. PubMed ID: 22684645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
    Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
    Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MEST score provides earlier risk prediction in lgA nephropathy.
    Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
    Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.